Atossa Therapeutics Inc (NASDAQ:ATOS)

0.7431
Delayed Data
As of Nov 30
 +0.013 / +1.78%
Today’s Change
0.50
Today|||52-Week Range
1.39
+40.61%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 4.75, with a high estimate of 5.50 and a low estimate of 4.00. The median estimate represents a +539.21% increase from the last price of 0.74.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Atossa Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.07
Sales
$0.00
Reporting Date
Mar 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -30.00%
 
 
 
 
 
 
Growthannually -14.29%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.